SOLARA ACTIVE PHARMA [SOLARAPP1] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

SOLARA ACTIVE PHARMA SCIENCES

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: SOLARA ACTIVE PHARMA SCIENCES wins in 5 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SOLARA ACTIVE PHARMA SCIENCES Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 300.92 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 1.05 10.82 SOLARA ACTIVE PHARMA SCIENCES
Debt-to-Equity Ratio 51.38 0.58 Divi's Laboratories Ltd.
PEG Ratio -1.02 4.63 Divi's Laboratories Ltd.
EV/EBITDA 11.85 48.63 SOLARA ACTIVE PHARMA SCIENCES
Profit Margin (TTM) -1.52% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 3.37% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 3.37% 29.65% Divi's Laboratories Ltd.
Return on Equity 0.05% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 0.02% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $1.73B $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 13.08% 0.83% SOLARA ACTIVE PHARMA SCIENCES
Price-to-Sales Ratio (TTM) 1.66 16.18 SOLARA ACTIVE PHARMA SCIENCES
Enterprise Value $19.97B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.59 15.86 SOLARA ACTIVE PHARMA SCIENCES
Gross Profit Margin (TTM) 46.53% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $231 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $-4.82 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.84 0.19 Divi's Laboratories Ltd.

SOLARA ACTIVE PHARMA SCIENCES vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SOLARAPP1
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SOLARA ACTIVE PHARMA SCIENCES12.87%2.56%2.47%-20.88%-31.50%-20.88%
Divi's Laboratories Ltd.0.30%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SOLARA ACTIVE PHARMA SCIENCES13.08%31.31%31.31%31.31%31.31%31.31%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Divi's Laboratories Ltd.

MetricSOLARAPP1DIVISLAB
Market Information
Market Cap i₹20.78B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i238253,443
90 Day Avg. Volume i704283,911
Last Close₹308.70₹6,596.50
52 Week Range₹247.95 - ₹511.00₹5,636.50 - ₹7,071.50
% from 52W High-39.59%-6.72%
All-Time High₹511.00 (Aug 29, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-39.59%-6.72%
Growth Metrics
Quarterly Revenue Growth0.16%0.12%
Quarterly Earnings Growth0.16%-0.01%
Financial Health
Profit Margin (TTM) i-0.02%0.24%
Operating Margin (TTM) i0.03%0.30%
Return on Equity (TTM) i0.00%0.15%
Debt to Equity (MRQ) i51.380.58
Cash & Liquidity
Book Value per Share (MRQ)₹293.20₹580.95
Cash per Share (MRQ)₹0.88₹122.95
Operating Cash Flow (TTM) i₹1.70B₹19.67B
Levered Free Cash Flow (TTM) i₹5.40M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: SOLARA ACTIVE PHARMA SCIENCES vs Divi's Laboratories Ltd.

MetricSOLARAPP1 (Apr 08, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i300.9267.11
Forward P/E iN/A53.75
PEG Ratio i-1.024.63
Price to Sales (TTM) i1.6616.18
Price to Book (MRQ) i1.0510.82
Market Capitalization
Market Capitalization i₹20.78B₹1.69T
Enterprise Value i₹19.97B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.5915.86
Enterprise to EBITDA i11.8548.63
Risk & Other Metrics
Beta i0.840.19
Book Value per Share (MRQ) i₹293.20₹580.95

Financial Statements Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP1 (2025)DIVISLAB (2025)
Revenue/Sales i12.41B93.25B
Cost of Goods Sold i6.46B38.70B
COGS % of Revenue i52.0%41.5%
Gross Profit i5.96B54.55B
Gross Margin i48.0%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i1.11B25.71B
Operating Margin i9.0%27.6%
EBITDA i2.05B33.19B
EBITDA Margin i16.5%35.6%
Pre-Tax Income i5.40M29.16B
Pre-Tax Income % of Revenue i0.0%31.3%
Income Tax i07.25B
Income Tax % of Revenue i0.0%7.8%
Net Income (Profit) i5.40M21.91B
Profit Margin i0.0%23.5%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP1 (2025)DIVISLAB (2025)
Cash & Equivalents i39.50M4.15B
Total Current Assets i7.29B100.81B
Total Current Assets % of Revenue i58.7%108.1%
Total Current Liabilities i9.44B14.52B
Total Current Liabilities % of Revenue i76.0%15.6%
Long-Term Debt i1.32B20.00M
Long-Term Debt % of Revenue i10.6%0.0%
Total Shareholders Equity i10.97B149.69B
Retained Earnings i-3.16B134.00B
Retained Earnings % of Revenue i-25.4%143.7%
Property, Plant & Equipment i7.96B3.19B

Cash Flow Statement Comparison

MetricSOLARAPP1 (2025)DIVISLAB (2025)
Operating Cash Flow i1.70B19.67B
Operating Cash Flow % of Revenue i13.7%21.1%
Capital Expenditures i3.80M-14.38B
Free Cash Flow i1.73B2.15B
FCF Margin i13.9%2.3%
Debt Repayment i-1.11BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSOLARAPP1DIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.00M265.47M
Float Shares i30.10M117.72M
% Held by Insiders i0.00%52.04%
% Held by Institutions i4.45%28.65%
% Held by Public i95.55%19.31%

Dividend Analysis & Yield Comparison: SOLARA ACTIVE PHARMA SCIENCES vs Divi's Laboratories Ltd.

MetricSOLARAPP1DIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025